Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

63.42%

Threshold

Crossed downwards

Timeline

Published

21.07.2020

Transaction

13.07.2020

Voting rights breakdown

Voting rights acquired6.41%
Voting rights sold63.42%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAK7H00067

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

(regarding certain sales positions)

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open